Connection

JEFFREY E GERSHENWALD to TOR Serine-Threonine Kinases

This is a "connection" page, showing publications JEFFREY E GERSHENWALD has written about TOR Serine-Threonine Kinases.
  1. Human melanoma cytolysis by combined inhibition of mammalian target of rapamycin and vascular endothelial growth factor/vascular endothelial growth factor receptor-2. Cancer Res. 2008 Jun 01; 68(11):4392-7.
    View in: PubMed
    Score: 0.012
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.